Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 15/20 | 0.76 |
| ▸ | NPC1 | O15118 | 14/20 | 0.76 |
| ▸ | SMN1; SMN2 | Q16637 | 6/20 | 0.72 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.72 |
| ▸ | PKM | P14618 | 3/20 | 0.71 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.71 |
| ▸ | NFKB2 | Q00653 | 2/20 | 0.71 |
| ▸ | RELA | Q04206 | 2/20 | 0.71 |
| ▸ | TP53 | P04637 | 2/20 | 0.71 |
| ▸ | MEN1 | O00255 | 4/20 | 0.69 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.69 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.69 |
| ▸ | POLB | P06746 | 1/20 | 0.68 |
| ▸ | MAPT | P10636 | 3/20 | 0.66 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.66 |
| ▸ | MAOB | P27338 | 3/20 | 0.64 |
| ▸ | GAA | P10253 | 1/20 | 0.64 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27181112 | 0.94 | RAB9A (0.85) | RAB9ANPC1SMN1; SMN2HSD17B10PKM | |
| SCHEMBL30926503 | 0.94 | RAB9A (0.85) | RAB9ANPC1SMN1; SMN2HSD17B10PKM | |
| SCHEMBL4486236 | 0.91 | RAB9A (0.80) | RAB9ANPC1SMN1; SMN2PKMNFKB1 | |
| SCHEMBL5173449 | 0.87 | RAB9A (0.74) | RAB9ANPC1SMN1; SMN2HSD17B10PKM | |
| SCHEMBL5171565 | 0.87 | RAB9A (1.00) | RAB9ANPC1SMN1; SMN2HSD17B10PKM | |
| SCHEMBL16621362 | 0.85 | NPC1 (0.72) | RAB9ANPC1SMN1; SMN2HSD17B10TP53 | |
| SCHEMBL5174946 | 0.84 | RAB9A (0.75) | RAB9ANPC1SMN1; SMN2HSD17B10PKM | |
| SCHEMBL5174923 | 0.84 | NPC1 (0.84) | RAB9ANPC1SMN1; SMN2HSD17B10PKM | |
| SCHEMBL5174929 | 0.84 | RAB9A (0.71) | RAB9ANPC1SMN1; SMN2HSD17B10PKM | |
| SCHEMBL8704332 | 0.84 | RAB9A (0.78) | RAB9ANPC1SMN1; SMN2HSD17B10PKM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200087248-A1 | Fluoroallylamine Derivative And Use Thereof | SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD. (CN) | 2020-03-19 | — | — | US | disclosed |
| EP-3617186-A1 | FLUOROALLYLAMINE DERIVATIVE AND USE THEREOF | Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (CN) | 2020-03-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200087248-A1 | Fluoroallylamine Derivative And Use Thereof | VAPB, VAPA, SLC28A1 | RAB9A 1093/4885NPC1 171/4885SMN1; SMN2 415/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.